erythrosine has been researched along with Myasthenia Gravis in 2 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kornguth, SE | 1 |
| Hanson, JC | 1 |
| Chun, RW | 1 |
| Heath, RG | 1 |
1 review available for erythrosine and Myasthenia Gravis
| Article | Year |
|---|---|
Schizophrenia: evidence of a pathologic immune mechanism.
Topics: Animals; Antigen-Antibody Reactions; Blood-Brain Barrier; Brain; Caudate Nucleus; Cerebral Ventricle | 1969 |
1 other study available for erythrosine and Myasthenia Gravis
| Article | Year |
|---|---|
Antineuronal antibodies in patients having myasthenia gravis.
Topics: Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Antibodies, Anti-Idiotypic; Autoimm | 1970 |